Sandra P. Reyna
Novartis (Switzerland)(CH)Tris Pharma (United States)(US)
Publications by Year
Research Areas
Neurogenetic and Muscular Disorders Research, RNA modifications and cancer, Congenital Anomalies and Fetal Surgery, Lipoproteins and Cardiovascular Health, Energy Harvesting in Wireless Networks
Most-Cited Works
- → Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study(2019)612 cited
- → Natural history of denervation in SMA: Relation to age, SMN2 copy number, and function(2005)471 cited
- → De novo mutations in ATP1A3 cause alternating hemiplegia of childhood(2012)418 cited
- → Natural history of infantile‐onset spinal muscular atrophy(2017)401 cited
- → Thrombotic Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series(2020)189 cited
- → Phase II Open Label Study of Valproic Acid in Spinal Muscular Atrophy(2009)177 cited
- →